TY  - JOUR

T1  - Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society

JO  - Neurology

PY  - 2004/04/27

AU  - French JA

AU  - Kanner AM

AU  - Bautista J

AU  - Abou-Khalil B

AU  - Browne T

AU  - Harden CL

AU  - Theodore WH

AU  - Bazil C

AU  - Stern J

AU  - Schachter SC

AU  - Bergen D et al

ED  - 

DO  - DOI: 10.1212/01.wnl.0000123695.22623.32

PB  - Ovid Technologies (Wolters Kluwer Health)

VL  - 62

IS  - 8

SP  - 1261

EP  - 1273

Y2  - 2024/12/22

ER  -